Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Obesity and the β cell: lessons from leptin
Kevin D. Niswender, Mark A. Magnuson
Kevin D. Niswender, Mark A. Magnuson
Published October 1, 2007
Citation Information: J Clin Invest. 2007;117(10):2753-2756. https://doi.org/10.1172/JCI33528.
View: Text | PDF
Commentary

Obesity and the β cell: lessons from leptin

  • Text
  • PDF
Abstract

In this issue of the JCI, Morioka et al. report on mice with a whole-pancreas knockout of the leptin receptor that exhibit improved glucose tolerance due to enhanced insulin secretion (see the related article beginning on page 2860). At first glance, their findings are very different from those reported in another recent study in which β cell–specific and hypothalamic knockout of the same gene caused obesity and impaired β cell function. The differences, which are understandable when one considers the body weights of the animals studied, provide new insight into the links among insulin, leptin action, and β cell function.

Authors

Kevin D. Niswender, Mark A. Magnuson

×

Figure 2

Homeostatic feedback loops affecting energy homeostasis and glucose homeostasis.

Options: View larger image (or click on image) Download as PowerPoint
Homeostatic feedback loops affecting energy homeostasis and glucose home...
Leptin and insulin are both secreted in proportion to energy availability. Whereas leptin secretion is indicative of adipose mass and thus is more chronic in nature, insulin secretion reflects both acute and chronic nutritional status. The findings of Morioka et al. (5) validate the existence of an adipose tissue–islet endocrine feedback loop. Insulin is both potently lipogenic and functions in the CNS to reduce nutrient intake. Leptin also acts on the CNS to reduce nutrient intake and directly on β cells in lean animals to inhibit insulin secretion. The findings of both Morioka et al. (5) and Covey et al. (6) suggest that as body weight increases, leptin signaling protects the β cell from the adverse effects of overnutrition. Thus, glucose and energy homeostasis should both be considered in a very broad manner that simultaneously takes into account the effects of glucose, insulin, and leptin in multiple tissues.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts